Phase 2 results of the RADIANCE trial: a randomized, double-blind, placebo-controlled trial of oral RPC1063 in relapsing multiple sclerosis Cohen J, Arnold DL, Comi G, Bar-Or A, Gujrathi S, Hartung JP, Olson A, Cravets M, Frohna PA, Selmaj K ACTRIMS-ECTRIMS 2014. 09/13/2014. Epub 1969 Dec 31. CommentRecommendBookmarkWatch